DaVita Inc. (NYSE:DVA) Given Average Rating of "Reduce" by Analysts

Key Points

• DaVita Inc. has received an average consensus rating of "Reduce" from analysts, with one sell rating and four hold ratings reported.
• The average 12-month price target for DaVita shares is set at $158.00, with recent adjustments from Barclays and Bank of America lowering their targets.
• DaVita's quarterly earnings exceeded expectations, reporting $2.95 earnings per share and a revenue of $3.38 billion for the quarter.

DaVita Inc. (NYSE:DVA - Get Free Report) has earned a consensus rating of "Reduce" from the five research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $158.00.

Several equities analysts have issued reports on the stock. Barclays decreased their price objective on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Truist Financial set a $148.00 price target on shares of DaVita in a research note on Friday, August 8th. Bank of America decreased their price target on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating on the stock in a research note on Wednesday, September 10th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Saturday, September 13th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of DaVita in a research note on Saturday, September 27th.

Insider Buying and Selling at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On DaVita

A number of institutional investors have recently bought and sold shares of DVA. Wealth Enhancement Advisory Services LLC raised its stake in DaVita by 2.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock worth $531,000 after purchasing an additional 69 shares during the period. Wellington Management Group LLP raised its stake in DaVita by 9.1% during the fourth quarter. Wellington Management Group LLP now owns 2,711 shares of the company's stock worth $405,000 after purchasing an additional 227 shares during the period. Rhumbline Advisers raised its stake in DaVita by 3.7% during the first quarter. Rhumbline Advisers now owns 139,124 shares of the company's stock worth $21,282,000 after purchasing an additional 4,999 shares during the period. Czech National Bank raised its stake in DaVita by 3.3% during the first quarter. Czech National Bank now owns 10,106 shares of the company's stock worth $1,546,000 after purchasing an additional 327 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. raised its stake in DaVita by 23.6% during the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,015 shares of the company's stock worth $308,000 after purchasing an additional 385 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Trading Down 0.8%

DVA traded down $1.05 during midday trading on Friday, hitting $131.05. 777,376 shares of the company traded hands, compared to its average volume of 814,061. The company has a market capitalization of $9.37 billion, a price-to-earnings ratio of 12.89, a PEG ratio of 0.95 and a beta of 1.13. DaVita has a 52-week low of $126.07 and a 52-week high of $179.60. The business has a 50 day simple moving average of $134.81 and a two-hundred day simple moving average of $140.10.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company's revenue was up 6.1% compared to the same quarter last year. During the same period last year, the firm posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Equities research analysts anticipate that DaVita will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.